PT1165106E - Composicoes e metodo para induzir apoptose em celulas de cancro da prostata, por m-adn e mcc - Google Patents
Composicoes e metodo para induzir apoptose em celulas de cancro da prostata, por m-adn e mccInfo
- Publication number
- PT1165106E PT1165106E PT00912310T PT00912310T PT1165106E PT 1165106 E PT1165106 E PT 1165106E PT 00912310 T PT00912310 T PT 00912310T PT 00912310 T PT00912310 T PT 00912310T PT 1165106 E PT1165106 E PT 1165106E
- Authority
- PT
- Portugal
- Prior art keywords
- dna
- mcc
- cancer cells
- prostate cancer
- compositions
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title abstract 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000006907 apoptotic process Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 241000187481 Mycobacterium phlei Species 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002421 cell wall Anatomy 0.000 abstract 1
- 229940055036 mycobacterium phlei Drugs 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12745199P | 1999-04-01 | 1999-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1165106E true PT1165106E (pt) | 2005-10-31 |
Family
ID=22430191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00912310T PT1165106E (pt) | 1999-04-01 | 2000-03-30 | Composicoes e metodo para induzir apoptose em celulas de cancro da prostata, por m-adn e mcc |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1165106B8 (https=) |
| JP (1) | JP2002541114A (https=) |
| AT (1) | ATE296106T1 (https=) |
| AU (1) | AU780909B2 (https=) |
| CA (1) | CA2366090C (https=) |
| CY (1) | CY1107455T1 (https=) |
| DE (1) | DE60020352T2 (https=) |
| ES (1) | ES2238996T3 (https=) |
| PT (1) | PT1165106E (https=) |
| WO (1) | WO2000059518A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000033879A1 (en) * | 1998-12-04 | 2000-06-15 | Bioniche Life Sciences Inc. | Method for the treatment of inflammation |
| US20030044352A1 (en) * | 2001-04-24 | 2003-03-06 | Phillips Nigel C. | Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100533576B1 (ko) * | 1997-08-05 | 2005-12-05 | 바이오니취 라이프 사이언시즈 인코포레이티드 | 세포증식 및 세포사멸 조절용 조성물 및 방법 |
-
2000
- 2000-03-30 WO PCT/CA2000/000342 patent/WO2000059518A2/en not_active Ceased
- 2000-03-30 DE DE60020352T patent/DE60020352T2/de not_active Expired - Lifetime
- 2000-03-30 EP EP00912310A patent/EP1165106B8/en not_active Expired - Lifetime
- 2000-03-30 CA CA2366090A patent/CA2366090C/en not_active Expired - Fee Related
- 2000-03-30 AT AT00912310T patent/ATE296106T1/de active
- 2000-03-30 PT PT00912310T patent/PT1165106E/pt unknown
- 2000-03-30 JP JP2000609081A patent/JP2002541114A/ja active Pending
- 2000-03-30 AU AU34135/00A patent/AU780909B2/en not_active Ceased
- 2000-03-30 ES ES00912310T patent/ES2238996T3/es not_active Expired - Lifetime
-
2005
- 2005-08-03 CY CY20051100946T patent/CY1107455T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3413500A (en) | 2000-10-23 |
| DE60020352D1 (de) | 2005-06-30 |
| EP1165106B8 (en) | 2005-07-27 |
| WO2000059518A2 (en) | 2000-10-12 |
| JP2002541114A (ja) | 2002-12-03 |
| ATE296106T1 (de) | 2005-06-15 |
| DE60020352T2 (de) | 2005-10-20 |
| WO2000059518A3 (en) | 2001-02-01 |
| CA2366090C (en) | 2011-05-24 |
| EP1165106A2 (en) | 2002-01-02 |
| EP1165106B1 (en) | 2005-05-25 |
| CA2366090A1 (en) | 2000-10-12 |
| ES2238996T3 (es) | 2005-09-16 |
| AU780909B2 (en) | 2005-04-21 |
| CY1107455T1 (el) | 2012-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fang et al. | Tumor-targeted induction of oxystress for cancer therapy | |
| McAdam et al. | Oxidative stress–induced protein damage inhibits DNA repair and determines mutation risk and therapeutic efficacy | |
| DE60027719D1 (de) | Krebstherapie | |
| BR0308854A (pt) | Benzazolas substituìdas e seus usos como inibidoras de quinase raf | |
| Jones et al. | Dual action of tirapazamine in the induction of DNA strand breaks | |
| DK0490077T3 (da) | Antisense-oligonukleotider til behandling af cancer | |
| KR960704582A (ko) | 텍사피린을 사용하는 방사선 감작방법(Radiation sentization using texaphyrins) | |
| BRPI0412885A (pt) | polipeptìdios, agentes de ligação especìficos, moléculas de ácido nucleico e linhas de células isoladas, células hospedeiras, composições e anticorpo ou domìnio de ligação de antìgeno e métodos de tratamento de cáncer e de tumor sólido num paciente, de detecção do nìvel do fator de crescimento hepatócito (hgf) numa amostra, de obtenção de anticorpo e de inibição da ligação de hgf a met e de diminuição ou prevenção da ligação de qualquer um dos agentes de ligação especìficos ao fator de crescimento hepatócito (hgf) | |
| BRPI0409919A (pt) | combinações para o tratamento de doenças envolvendo proliferação, migração ou apoptose celular de células de células de mieloma, ou angiogênese | |
| UA86586C2 (ru) | Комбинация для лечения заболеваний, связанных с клеточной пролиферацией, миграцией или апоптозом клеток миеломы или с ангиогенезом | |
| BR0108728A (pt) | Combinação farmacêutica terapêutica, e, método para tratar um c ncer. | |
| EA200300934A1 (ru) | Агенты и способы, предназначенные для лечения опухолевых заболеваний | |
| Di Stasi et al. | Updates in intravesical electromotive drug administration® of mitomycin-C for non-muscle invasive bladder cancer | |
| CA2299548A1 (en) | Composition and method for regulating cell proliferation and cell death | |
| PT1165106E (pt) | Composicoes e metodo para induzir apoptose em celulas de cancro da prostata, por m-adn e mcc | |
| DE69533873D1 (de) | Krebstherapie mit lymphotoxin | |
| PT1051187E (pt) | Tratamento de linfomas foliculares usando inibidores da via da linfotoxina (lt) | |
| NO20050793L (no) | Anvendelse av urease for inhibering av kreftcellevekst | |
| DE69829316D1 (de) | Behandlung des harnblasenkrebses durch mycobacterium phlei zellwand | |
| ATE243522T1 (de) | Verwendung von tall-104 zellen in kombination mit adriamyzin oder cisplatin zur behandlung von malignen tumoren | |
| CA2194485A1 (en) | Endothelial lining effects and treatment of vasospastic disorders | |
| Rose | A proposal for a new direction to treat cancer | |
| DE69919386D1 (de) | Zusammensetzung zur behandlung von entzündungen | |
| ES2152664T3 (es) | Combinacion de cis-4-hidroxi-l-prolina y n-metil-cis-4-hidroxi-l-prolina para aplicacion como agente terapeutico, especialmente para el tratamiento contra el cancer. | |
| Gevorkyan et al. | Anticancer efficacy of hydroxyethylthiamine diphosphate in vivo |